Company Filing History:
Years Active: 2012-2016
Title: Neera Jain: Innovator in Cytotoxic Drug Conjugates
Introduction
Neera Jain is a prominent inventor based in New City, NY (US). She has made significant contributions to the field of cytotoxic drug conjugates, holding a total of 4 patents. Her work focuses on developing innovative methods for preparing drug/carrier conjugates that enhance drug loading and reduce aggregation.
Latest Patents
Neera Jain's latest patents include groundbreaking advancements in calicheamicin derivative-carrier conjugates. These patents describe methods for preparing monomeric cytotoxic drug/carrier conjugates with significantly higher drug loading than previously reported procedures. Additionally, her work addresses decreased aggregation and low conjugate fraction (LCF). Jain's patents also cover cytotoxic drug derivative/antibody conjugates, compositions comprising these conjugates, and their various uses. Notably, she has developed monomeric calicheamicin derivative/anti-CD22 antibody conjugates, further expanding the applications of her innovative work.
Career Highlights
Neera Jain is currently associated with Wyeth Holdings Corporation, where she continues to push the boundaries of research in her field. Her dedication to innovation has positioned her as a key figure in the development of advanced therapeutic solutions.
Collaborations
Throughout her career, Neera has collaborated with notable colleagues, including Arthur Kunz and Justin Keith Moran. These partnerships have fostered a collaborative environment that enhances the research and development of new technologies.
Conclusion
Neera Jain's contributions to the field of cytotoxic drug conjugates exemplify her commitment to innovation and excellence. Her patents and ongoing research continue to pave the way for advancements in medical therapies.